Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metlife (MET) EBITDA (2016 - 2025)

Metlife (MET) has 17 years of EBITDA data on record, last reported at $3.2 billion in Q3 2025.

  • For Q3 2025, EBITDA fell 33.92% year-over-year to $3.2 billion; the TTM value through Sep 2025 reached $10.7 billion, down 14.04%, while the annual FY2024 figure was $217.0 million, 99.03% down from the prior year.
  • EBITDA reached $3.2 billion in Q3 2025 per MET's latest filing, up from $1.1 billion in the prior quarter.
  • Across five years, EBITDA topped out at $7.2 billion in Q4 2023 and bottomed at -$15.3 billion in Q2 2022.
  • Average EBITDA over 5 years is -$1.2 billion, with a median of $347.0 million recorded in 2024.
  • Peak YoY movement for EBITDA: plummeted 169762.5% in 2022, then skyrocketed 6021.05% in 2025.
  • A 5-year view of EBITDA shows it stood at $8.0 million in 2021, then tumbled by 169762.5% to -$13.6 billion in 2022, then surged by 153.41% to $7.2 billion in 2023, then plummeted by 53.19% to $3.4 billion in 2024, then fell by 5.78% to $3.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $3.2 billion in Q3 2025, $1.1 billion in Q2 2025, and $3.0 billion in Q1 2025.